Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/21506
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNewell, Michaelen_UK
dc.contributor.authorHunter, Angusen_UK
dc.contributor.authorLawrence, Claireen_UK
dc.contributor.authorTipton, Kevinen_UK
dc.contributor.authorGalloway, S Den_UK
dc.date.accessioned2017-06-08T23:16:50Z-
dc.date.available2017-06-08T23:16:50Z-
dc.date.issued2015-06en_UK
dc.identifier.urihttp://hdl.handle.net/1893/21506-
dc.description.abstractIn an investigator-blind, randomised cross-over design, male cyclists (mean±SD) age 34.0 (± 10.2) years, body mass 74.6 (±7.9) kg, stature 178.3 (±8.0) cm, peak power output (PPO) 393 (±36) W, and VO2max 62 (±9) ml·kg-1·min-1 training for >6h/wk for >3y (n=20) completed four experimental trials. Each trial consisted of a 2h constant load ride at 95% of lactate threshold (185 ± 25W) then a work-matched time trial task (~30min at 70% of PPO). Three commercially available carbohydrate (CHO) beverages, plus a control (water), were administered during the 2h ride providing 0, 20, 39 or 64g·h-1 of CHO at a fluid intake rate of 1L·h-1. Performance was assessed by time to complete the time trial task, mean power output sustained, and pacing strategy used. Mean task completion time (min:sec ± SD) for 39g·h-1 (34:19.5 ± 03:07.1, p=0.006) and 64g·h-1 (34:11.3 ± 03:08.5 p=0.004) of CHO were significantly faster than control (37:01.9 ± 05:35.0). The mean percentage improvement from control was -6.1% (95% CI: -11.3 to -1.0) and -6.5% (95% CI: -11.7 to -1.4) in the 39 and 64g·h-1 trials respectively. The 20g·h-1 (35:17.6 ± 04:16.3) treatment did not reach statistical significance compared to control (p = 0.126) despite a mean improvement of -3.7% (95% CI -8.8 to 1.5%). No further differences between CHO trials were reported. No interaction between CHO dose and pacing strategy occurred. 39 and 64g·h-1 of CHO were similarly effective at improving endurance cycling performance compared to a 0g·h-1 control in our trained cyclists.en_UK
dc.language.isoenen_UK
dc.publisherHuman Kineticsen_UK
dc.relationNewell M, Hunter A, Lawrence C, Tipton K & Galloway SD (2015) The Ingestion of 39 or 64 g·hr-1 of Carbohydrate is Equally Effective at Improving Endurance Exercise Performance in Cyclists. International Journal of Sport Nutrition and Exercise Metabolism, 25 (3), pp. 285-292. https://doi.org/10.1123/ijsnem.2014-0134en_UK
dc.rightsPublisher allows this work to be made available in this repository. This article will be published in International Journal of Sport Nutrition and Exercise Metabolism by Human Kinetics: http://dx.doi.org/10.1123/ijsnem.2014-0134en_UK
dc.subjectNutritionen_UK
dc.subjectmetabolismen_UK
dc.subjectTime trialen_UK
dc.titleThe Ingestion of 39 or 64 g·hr-1 of Carbohydrate is Equally Effective at Improving Endurance Exercise Performance in Cyclistsen_UK
dc.typeJournal Articleen_UK
dc.identifier.doi10.1123/ijsnem.2014-0134en_UK
dc.identifier.pmid25203688en_UK
dc.citation.jtitleInternational Journal of Sport Nutrition and Exercise Metabolismen_UK
dc.citation.issn1526-484Xen_UK
dc.citation.volume25en_UK
dc.citation.issue3en_UK
dc.citation.spage285en_UK
dc.citation.epage292en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusAM - Accepted Manuscripten_UK
dc.contributor.funderGlaxoSmithKlineen_UK
dc.author.emails.d.r.galloway@stir.ac.uken_UK
dc.citation.date31/08/2014en_UK
dc.contributor.affiliationUniversity of Stirlingen_UK
dc.contributor.affiliationSporten_UK
dc.contributor.affiliationGlaxoSmithKlineen_UK
dc.contributor.affiliationSporten_UK
dc.contributor.affiliationSporten_UK
dc.identifier.isiWOS:000357661300008en_UK
dc.identifier.scopusid2-s2.0-84940484853en_UK
dc.identifier.wtid603638en_UK
dc.contributor.orcid0000-0001-7562-6145en_UK
dc.contributor.orcid0000-0002-6545-8122en_UK
dc.contributor.orcid0000-0002-1622-3044en_UK
dc.date.accepted2014-08-26en_UK
dcterms.dateAccepted2014-08-26en_UK
dc.date.filedepositdate2015-02-17en_UK
dc.relation.funderprojectCarbohydrate dose-response study.en_UK
dc.relation.funderrefPO: 4086143en_UK
rioxxterms.apcnot requireden_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionAMen_UK
local.rioxx.authorNewell, Michael|en_UK
local.rioxx.authorHunter, Angus|0000-0001-7562-6145en_UK
local.rioxx.authorLawrence, Claire|en_UK
local.rioxx.authorTipton, Kevin|0000-0002-6545-8122en_UK
local.rioxx.authorGalloway, S D|0000-0002-1622-3044en_UK
local.rioxx.projectPO: 4086143|GlaxoSmithKline|http://dx.doi.org/10.13039/100004330en_UK
local.rioxx.freetoreaddate2015-02-17en_UK
local.rioxx.licencehttp://www.rioxx.net/licenses/all-rights-reserved|2015-02-17|en_UK
local.rioxx.filenameNewell ML_ijsnem_2014-0134-in press.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source1526-484Xen_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
Newell ML_ijsnem_2014-0134-in press.pdfFulltext - Accepted Version665.05 kBAdobe PDFView/Open


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.